Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)

被引：1
|
作者：
Mansour-Ghanaei, Fariborz [1 ]
Vahhabi-Moghaddam, Masrour [2 ]
Joukar, Farahnaz [1 ]
Asgharnezhad, Mehrnaz [1 ]
Kiyani, Noufar [2 ]
机构：
[1] Guilan Univ Med Sci, GLDRC, Rasht, Iran
[2] Guilan Univ Med Sci, Poursina Hosp, Dept Radiol, Rasht, Iran
来源：
CASPIAN JOURNAL OF INTERNAL MEDICINE | 2013年 / 4卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：797 / 798
页数：2
相关论文
共 50 条
  • [1] NASH - Nonalcoholic steatohepatitis
    Blechacz, B
    Stremmel, W
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (01): : 77 - 90
  • [2] Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Kogachi, Shannon
    Noureddin, Mazen
    CLINICAL THERAPEUTICS, 2021, 43 (03) : 455 - 472
  • [3] Pathogenesis of nonalcoholic steatohepatitis (NASH)
    Pirlich, M
    Lochs, H
    Schmidt, HHJ
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (05): : 441 - 442
  • [4] ASSESSING THE USE OF NONINVASIVE BIOMARKERS IN DRUG DEVELOPMENT FOR NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH).
    Tian, X.
    Li, S.
    Kim, I.
    Saluja, B.
    Doddapaneni, S.
    Sahajwalla, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S30 - S30
  • [5] A novel noninvasive diagnostic method for nonalcoholic steatohepatitis (NASH) using two glycobiomarkers
    Kamada, Yoshihiro
    Ono, Masafumi
    Hyogo, Hideyuki
    Fujii, Hideki
    Sumida, Yoshio
    Mori, Kohjiroh
    Tanaka, Saiyu
    Yamada, Makoto
    Akita, Maaya
    Mizutani, Kayo
    Fujii, Hironobu
    Yamamoto, Akiko
    Takamatsu, Shinji
    Yoshida, Yuichi
    Itoh, Yoshito
    Kawada, Norifumi
    Chayama, Kazuaki
    Saibara, Toshiji
    Takehara, Tetsuo
    Miyoshi, Eiji
    HEPATOLOGY, 2015, 62 : 1258A - 1259A
  • [6] CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Harrison, Stephen A.
    Lawitz, Eric J.
    Wong, Vincent Wai-Sun
    Anstee, Quentin M.
    Trauner, Michael H.
    Romero-Gomez, Manuel
    Bhandari, Bal
    Abdelmalek, Manal F.
    Sanyal, Arun J.
    Patel, Keyur
    Leroy, Vincent
    Bureau, Christophe
    Sasso, Magali
    Fournier, Celine D.
    Sandrin, Laurent
    Han, Ling
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Myers, Robert P.
    Goodman, Zackary
    Younossi, Youssef
    HEPATOLOGY, 2019, 70 : 1349A - 1350A
  • [7] Predictors of fibrosis in nonalcoholic steatohepatitis (NASH)
    Copaci, I
    Micu, L
    Cojocaru, L
    Voiculescu, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 192 - 192
  • [8] Definition and management of nonalcoholic steatohepatitis (NASH)
    Hütteroth, TH
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 : S64 - S67
  • [9] Nonalcoholic steatohepatitis (NASH) drugs market
    Cassidy, Sorcha
    Syed, Basharut A.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 745 - 746
  • [10] Nonalcoholic steatohepatitis (NASH): therapeutic approaches
    Buscher, HP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S60 - S62
12345